Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Curetis
Curetis
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Curetis
Revenue
€1.4 M
FY, 2018
Curetis Summary
Company Summary
Overview
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.
Type
Subsidiary
Status
Active
Founded
2007
HQ
Holzgerlingen, DE
|
view all locations
Website
https://www.curetis.com
Cybersecurity rating
Sectors
Healthcare
biotech
Homepage
Linkedin
youtube
Table of Contents
Key People
Locations
Financials
Competitors
Key People
Oliver Schacht,
CEO
Johannes Bacher,
COO
Andreas Boos,
CTO
Linkedin
Chris Emery,
President & CEO, Curetis USA
and 8 others
Locations
View all
1 location detected
Holzgerlingen, Baden-Württemberg
HQ
Germany
42 Max-Eyth-Straße
Curetis Financials
Summary Financials
Revenue (Q3, 2019)
€295.0K
Gross profit (Q3, 2019)
€394.0K
Net income (Q3, 2019)
(€5.3M)
Cash (Q3, 2019)
€3.0M
EBIT (Q3, 2019)
(€4.9M)
Competitors and Similar Companies
Veracyte
Healthcare - Public
Streck
Healthcare - Private
Novoprotein
Healthcare - Public
Certified Laboratories
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top